Vivimed Labs hits fresh 52-week high after Ashish Kacholia buys around 13.74 lakh equity shares

By: | Updated: September 28, 2016 4:12 PM

Shares of Vivimed Labs gained nearly 12 per cent intraday and also touched their fresh 52-week high on Wednesday after investor Ashish Kacholia acquired nearly 2 per cent stake in the company through open market.

BSE Sensex, NSE Nifty, Ashish Kacholia Shares of Vivimed Labs gained nearly 12 per cent intraday and also touched their fresh 52-week high on Wednesday after investor Ashish Kacholia acquired nearly 2 per cent stake in the company through open market. (Photo: Reuters)

Shares of Vivimed Labs gained nearly 12 per cent intraday and also touched their fresh 52-week high on Wednesday after investor Ashish Kacholia acquired nearly 2 per cent stake in the company through open market. At 11.43 am, shares of the pharmaceuticals company were trading 9.40 per cent up at Rs 112.30 and have touched a high and low of Rs 114.95 and Rs 106, respectively, in trade so far. Stocks of the company ended 9.74 per cent up at Rs 112.65.

On September 27, Kacholia bought around 13.74 lakh shares of Vivimed Labs at an average price of Rs 90.50, according to the data available with NSE. RBA Finance & Invt also bought 22.20 lakh equity shares at an average price of Rs 90.50. However, Nylim Jacob Ballas India Fund III LLC sold nearly 48.75 lakh shares at an average price of Rs 93.72.

Vivimed labs, bse sensex, nse nifty

Chetan Rasikhlal Shah bought 4.58 lakh shares at Rs 101.20 and sold 3.70 lakh shares at Rs 101.43 on Tuesday.

In the past one year, shares of Vivimed Labs have risen nearly 68 per cent to Rs 102.65 till September 27, whereas BSE Sensex gained 10 per cent during the same period.

For the quarter ended June 30, 2016, Vivimed Labs reported net profit of Rs 27.86 crore, up 15.24 per cent, against Rs 24.17 crore in the corresponding quarter a year ago. Net sales of the company increased by 10.65 per cent year-on-year to Rs 366.83 crore for the quarter under review.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition